MET and hepatocellular carcinoma: It has recently been shown that TVB-3664 suppresses AKT mediated hepatic steatosis in a mouse HCC model and that specific oncogene-driven subsets of HCC such as the MET-high/PTEN low are particularly FASN-dependent35.